Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up

BACKGROUND: Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is a treatment option for patients with type 1 diabetes mellitus (T1DM). Aim of the present study was to describe the long-term course of glycaemic control, complications, health related quality of life (HRQOL)...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijk, Peter R, Logtenberg, Susan JJ, Groenier, Klaas H, Gans, Rijk OB, Kleefstra, Nanne, Bilo, Henk JG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029992/
https://www.ncbi.nlm.nih.gov/pubmed/24708696
http://dx.doi.org/10.1186/1472-6823-14-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029992/
https://www.ncbi.nlm.nih.gov/pubmed/24708696
http://dx.doi.org/10.1186/1472-6823-14-30

Ejemplares similares